Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024
Compare Balance Sheet Results of Vaishali Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
26.09
35.27
-9.18
-26.03%
Share Warrants & Outstandings
Total Reserve
38.82
28.52
10.30
36.12%
Shareholder's Funds
64.92
63.79
1.13
1.77%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
7.36
39.40
-32.04
-81.32%
Secured Loans
7.36
0.00
7.36
0.00%
Unsecured Loans
0.00
39.40
-39.40
-100.00%
Deferred Tax Assets / Liabilities
-0.18
-5.15
4.97
96.50%
Other Long Term Liabilities
0.42
0.16
0.26
162.50%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.26
0.11
0.15
136.36%
Total Non-Current Liabilities
4.69
34.52
-29.83
-86.41%
Current Liabilities
Trade Payables
27.14
11.38
15.76
138.49%
Other Current Liabilities
5.43
3.85
1.58
41.04%
Short Term Borrowings
7.46
0.00
7.46
0.00%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
40.05
15.23
24.82
162.97%
Total Liabilities
109.66
113.54
-3.88
-3.42%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.46
24.02
-20.56
-85.60%
Less: Accumulated Depreciation
2.14
0.12
2.02
1,683.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.32
23.90
-22.58
-94.48%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
3.51
-3.51
-100.00%
Intangible assets under development
0.25
0.00
0.25
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.43
52.61
-52.18
-99.18%
Long Term Loans & Advances
1.05
12.66
-11.61
-91.71%
Other Non Current Assets
1.61
7.90
-6.29
-79.62%
Total Non-Current Assets
5.18
100.86
-95.68
-94.86%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.81
9.77
-4.96
-50.77%
Sundry Debtors
46.72
0.16
46.56
29,100.00%
Cash and Bank
1.84
0.47
1.37
291.49%
Other Current Assets
0.52
0.07
0.45
642.86%
Short Term Loans and Advances
50.59
2.21
48.38
2,189.14%
Total Current Assets
104.48
12.68
91.80
723.97%
Net Current Assets (Including Current Investments)
64.43
-2.55
66.98
2,626.67%
Total Current Assets Excluding Current Investments
104.48
12.68
91.80
723.97%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
109.66
113.54
-3.88
-3.42%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
8.50
39.40
-30.90
-78.43%
Book Value per share (adjusted)
4.98
18.09
-13.11
-72.47%
Annual - Borrowings
Borrowings 11.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Annual - Investments
Investments 0.43 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 104.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024






